Jamaica
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.27 (0.24 - 0.30) | 2019 | Modelled | IHME |
0.27 (0.24 - 0.30) | 2018 | Modelled | IHME |
0.27 (0.24 - 0.31) | 2017 | Modelled | IHME |
0.28 (0.25 - 0.32) | 2016 | Modelled | IHME |
0.29 (0.25 - 0.33) | 2015 | Modelled | IHME |
0.3 (0.26 - 0.34) | 2014 | Modelled | IHME |
0.3 (0.27 - 0.34) | 2013 | Modelled | IHME |
0.31 (0.27 - 0.35) | 2012 | Modelled | IHME |
0.31 (0.27 - 0.36) | 2011 | Modelled | IHME |
0.32 (0.28 - 0.37) | 2010 | Modelled | IHME |
0.33 (0.28 - 0.37) | 2009 | Modelled | IHME |
0.33 (0.29 - 0.38) | 2008 | Modelled | IHME |
0.34 (0.29 - 0.39) | 2007 | Modelled | IHME |
0.35 (0.29 - 0.40) | 2006 | Modelled | IHME |
0.35 (0.30 - 0.40) | 2005 | Modelled | IHME |
0.36 (0.30 - 0.41) | 2004 | Modelled | IHME |
0.36 (0.31 - 0.41) | 2003 | Modelled | IHME |
0.36 (0.31 - 0.42) | 2002 | Modelled | IHME |
0.37 (0.31 - 0.42) | 2001 | Modelled | IHME |
0.37 (0.32 - 0.43) | 2000 | Modelled | IHME |
0.37 (0.32 - 0.43) | 1999 | Modelled | IHME |
0.37 (0.32 - 0.43) | 1998 | Modelled | IHME |
0.38 (0.32 - 0.44) | 1997 | Modelled | IHME |
0.38 (0.32 - 0.44) | 1996 | Modelled | IHME |
0.38 (0.32 - 0.44) | 1995 | Modelled | IHME |
0.39 (0.33 - 0.45) | 1994 | Modelled | IHME |
0.39 (0.33 - 0.45) | 1993 | Modelled | IHME |
0.39 (0.33 - 0.46) | 1992 | Modelled | IHME |
0.4 (0.33 - 0.46) | 1991 | Modelled | IHME |
0.4 (0.34 - 0.47) | 1990 | Modelled | IHME |
0.49 (0.11 - 1.41) | 2015 | Modelled | WHO |
5 (2.40 - 5.70) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
3.76 (2.65 - 5.29) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.01 (0.01 - 0.02) | 2019 | Modelled | IHME |
0.01 (0.01 - 0.02) | 2018 | Modelled | IHME |
0.01 (0.01 - 0.02) | 2017 | Modelled | IHME |
0.01 (0.01 - 0.02) | 2016 | Modelled | IHME |
0.02 (0.01 - 0.02) | 2015 | Modelled | IHME |
0.02 (0.01 - 0.02) | 2014 | Modelled | IHME |
0.02 (0.01 - 0.02) | 2013 | Modelled | IHME |
0.02 (0.01 - 0.03) | 2012 | Modelled | IHME |
0.02 (0.01 - 0.03) | 2011 | Modelled | IHME |
0.02 (0.02 - 0.03) | 2010 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2009 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2008 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2007 | Modelled | IHME |
0.04 (0.03 - 0.05) | 2006 | Modelled | IHME |
0.04 (0.03 - 0.06) | 2005 | Modelled | IHME |
0.06 (0.05 - 0.09) | 2004 | Modelled | IHME |
0.1 (0.07 - 0.14) | 2003 | Modelled | IHME |
0.14 (0.11 - 0.20) | 2002 | Modelled | IHME |
0.18 (0.13 - 0.25) | 2001 | Modelled | IHME |
0.2 (0.14 - 0.27) | 2000 | Modelled | IHME |
0.2 (0.15 - 0.28) | 1999 | Modelled | IHME |
0.21 (0.15 - 0.28) | 1998 | Modelled | IHME |
0.21 (0.15 - 0.28) | 1997 | Modelled | IHME |
0.21 (0.15 - 0.28) | 1996 | Modelled | IHME |
0.22 (0.15 - 0.29) | 1995 | Modelled | IHME |
0.22 (0.15 - 0.29) | 1994 | Modelled | IHME |
0.22 (0.16 - 0.29) | 1993 | Modelled | IHME |
0.22 (0.16 - 0.30) | 1992 | Modelled | IHME |
0.23 (0.16 - 0.30) | 1991 | Modelled | IHME |
0.23 (0.16 - 0.30) | 1990 | Modelled | IHME |
0.16 (0.04 - 0.51) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
9,452 (7,967 - 11,067) | 1990 | Modelled | IHME |
9,429 (7,961 - 11,034) | 1991 | Modelled | IHME |
9,426 (7,995 - 10,987) | 1992 | Modelled | IHME |
9,437 (8,002 - 10,974) | 1993 | Modelled | IHME |
9,460 (8,042 - 10,981) | 1994 | Modelled | IHME |
9,494 (8,052 - 11,030) | 1995 | Modelled | IHME |
9,540 (8,124 - 11,071) | 1996 | Modelled | IHME |
9,591 (8,159 - 11,104) | 1997 | Modelled | IHME |
9,641 (8,209 - 11,150) | 1998 | Modelled | IHME |
9,680 (8,244 - 11,209) | 1999 | Modelled | IHME |
9,700 (8,263 - 11,278) | 2000 | Modelled | IHME |
9,700 (8,290 - 11,180) | 2001 | Modelled | IHME |
9,682 (8,261 - 11,107) | 2002 | Modelled | IHME |
9,646 (8,218 - 11,047) | 2003 | Modelled | IHME |
9,593 (8,150 - 11,011) | 2004 | Modelled | IHME |
9,523 (8,093 - 10,954) | 2005 | Modelled | IHME |
9,424 (8,016 - 10,760) | 2006 | Modelled | IHME |
9,289 (7,961 - 10,562) | 2007 | Modelled | IHME |
9,130 (7,843 - 10,327) | 2008 | Modelled | IHME |
8,963 (7,774 - 10,170) | 2009 | Modelled | IHME |
8,805 (7,661 - 10,056) | 2010 | Modelled | IHME |
8,663 (7,595 - 9,810) | 2011 | Modelled | IHME |
8,525 (7,481 - 9,611) | 2012 | Modelled | IHME |
8,388 (7,362 - 9,419) | 2013 | Modelled | IHME |
8,239 (7,242 - 9,335) | 2014 | Modelled | IHME |
8,073 (7,069 - 9,173) | 2015 | Modelled | IHME |
7,849 (6,884 - 8,883) | 2016 | Modelled | IHME |
7,667 (6,691 - 8,671) | 2017 | Modelled | IHME |
7,581 (6,648 - 8,513) | 2018 | Modelled | IHME |
7,546 (6,629 - 8,503) | 2019 | Modelled | IHME |
143,000 (69,000 - 164,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
1.2 (0.86 - 1.62) | 2019 | Modelled | IHME |
1.18 (0.86 - 1.57) | 2018 | Modelled | IHME |
1.17 (0.87 - 1.53) | 2017 | Modelled | IHME |
1.15 (0.89 - 1.50) | 2016 | Modelled | IHME |
1.15 (0.90 - 1.47) | 2015 | Modelled | IHME |
1.17 (0.94 - 1.45) | 2014 | Modelled | IHME |
1.15 (0.94 - 1.42) | 2013 | Modelled | IHME |
1.23 (1 - 1.51) | 2012 | Modelled | IHME |
1.41 (1.14 - 1.74) | 2011 | Modelled | IHME |
1.33 (1.08 - 1.62) | 2010 | Modelled | IHME |
1.5 (1.21 - 1.86) | 2009 | Modelled | IHME |
1.43 (1.15 - 1.77) | 2008 | Modelled | IHME |
1.23 (0.98 - 1.53) | 2007 | Modelled | IHME |
1.07 (0.86 - 1.33) | 2006 | Modelled | IHME |
1.05 (0.84 - 1.31) | 2005 | Modelled | IHME |
1.1 (0.89 - 1.36) | 2004 | Modelled | IHME |
1.17 (0.95 - 1.44) | 2003 | Modelled | IHME |
1.21 (0.97 - 1.50) | 2002 | Modelled | IHME |
1.21 (0.97 - 1.52) | 2001 | Modelled | IHME |
1.2 (0.96 - 1.51) | 2000 | Modelled | IHME |
1.27 (1.02 - 1.61) | 1999 | Modelled | IHME |
1.31 (1.04 - 1.65) | 1998 | Modelled | IHME |
1.35 (1.04 - 1.73) | 1997 | Modelled | IHME |
1.4 (1.07 - 1.82) | 1996 | Modelled | IHME |
1.41 (1.06 - 1.84) | 1995 | Modelled | IHME |
1.52 (1.15 - 1.97) | 1994 | Modelled | IHME |
1.57 (1.22 - 2) | 1993 | Modelled | IHME |
1.57 (1.25 - 1.98) | 1992 | Modelled | IHME |
1.57 (1.26 - 1.94) | 1991 | Modelled | IHME |
1.66 (1.34 - 2.05) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
34 (24 - 45) | 2019 | Modelled | IHME |
33 (24 - 44) | 2018 | Modelled | IHME |
33 (24 - 43) | 2017 | Modelled | IHME |
32 (25 - 42) | 2016 | Modelled | IHME |
32 (25 - 41) | 2015 | Modelled | IHME |
33 (26 - 40) | 2014 | Modelled | IHME |
32 (26 - 40) | 2013 | Modelled | IHME |
34 (28 - 42) | 2012 | Modelled | IHME |
39 (32 - 48) | 2011 | Modelled | IHME |
37 (30 - 45) | 2010 | Modelled | IHME |
41 (33 - 51) | 2009 | Modelled | IHME |
39 (31 - 49) | 2008 | Modelled | IHME |
34 (27 - 42) | 2007 | Modelled | IHME |
29 (23 - 36) | 2006 | Modelled | IHME |
28 (23 - 35) | 2005 | Modelled | IHME |
30 (24 - 37) | 2004 | Modelled | IHME |
31 (25 - 39) | 2003 | Modelled | IHME |
32 (26 - 40) | 2002 | Modelled | IHME |
32 (26 - 40) | 2001 | Modelled | IHME |
31 (25 - 40) | 2000 | Modelled | IHME |
33 (26 - 42) | 1999 | Modelled | IHME |
34 (27 - 42) | 1998 | Modelled | IHME |
34 (27 - 44) | 1997 | Modelled | IHME |
35 (27 - 46) | 1996 | Modelled | IHME |
35 (26 - 46) | 1995 | Modelled | IHME |
37 (28 - 48) | 1994 | Modelled | IHME |
38 (30 - 49) | 1993 | Modelled | IHME |
38 (30 - 48) | 1992 | Modelled | IHME |
38 (30 - 46) | 1991 | Modelled | IHME |
39 (32 - 48) | 1990 | Modelled | IHME |
97 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
26 (19 - 34) | 2019 | Modelled | IHME |
26 (19 - 34) | 2018 | Modelled | IHME |
26 (20 - 35) | 2017 | Modelled | IHME |
26 (20 - 35) | 2016 | Modelled | IHME |
26 (20 - 35) | 2015 | Modelled | IHME |
26 (20 - 35) | 2014 | Modelled | IHME |
27 (20 - 35) | 2013 | Modelled | IHME |
27 (21 - 36) | 2012 | Modelled | IHME |
28 (21 - 37) | 2011 | Modelled | IHME |
28 (21 - 37) | 2010 | Modelled | IHME |
29 (22 - 37) | 2009 | Modelled | IHME |
28 (21 - 37) | 2008 | Modelled | IHME |
27 (21 - 36) | 2007 | Modelled | IHME |
27 (20 - 36) | 2006 | Modelled | IHME |
27 (20 - 36) | 2005 | Modelled | IHME |
27 (20 - 36) | 2004 | Modelled | IHME |
27 (21 - 36) | 2003 | Modelled | IHME |
28 (21 - 36) | 2002 | Modelled | IHME |
27 (20 - 36) | 2001 | Modelled | IHME |
27 (20 - 36) | 2000 | Modelled | IHME |
28 (20 - 37) | 1999 | Modelled | IHME |
28 (21 - 37) | 1998 | Modelled | IHME |
28 (21 - 37) | 1997 | Modelled | IHME |
28 (21 - 37) | 1996 | Modelled | IHME |
28 (20 - 37) | 1995 | Modelled | IHME |
28 (21 - 37) | 1994 | Modelled | IHME |
28 (21 - 37) | 1993 | Modelled | IHME |
28 (21 - 37) | 1992 | Modelled | IHME |
28 (21 - 37) | 1991 | Modelled | IHME |
28 (21 - 37) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
96 | 2019 | Survey/reported | WHO/UNICEF |
95 | 2020 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Planned for 2020
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.64 (1.32 - 2.04) | 2019 | Modelled | IHME |
1.63 (1.31 - 2.01) | 2018 | Modelled | IHME |
1.61 (1.29 - 1.99) | 2017 | Modelled | IHME |
1.58 (1.27 - 1.96) | 2016 | Modelled | IHME |
1.56 (1.26 - 1.93) | 2015 | Modelled | IHME |
1.56 (1.25 - 1.93) | 2014 | Modelled | IHME |
1.55 (1.24 - 1.91) | 2013 | Modelled | IHME |
1.55 (1.24 - 1.91) | 2012 | Modelled | IHME |
1.55 (1.23 - 1.91) | 2011 | Modelled | IHME |
1.54 (1.23 - 1.91) | 2010 | Modelled | IHME |
1.54 (1.23 - 1.91) | 2009 | Modelled | IHME |
1.53 (1.23 - 1.90) | 2008 | Modelled | IHME |
1.53 (1.23 - 1.90) | 2007 | Modelled | IHME |
1.53 (1.23 - 1.90) | 2006 | Modelled | IHME |
1.52 (1.23 - 1.90) | 2005 | Modelled | IHME |
1.53 (1.23 - 1.90) | 2004 | Modelled | IHME |
1.54 (1.24 - 1.92) | 2003 | Modelled | IHME |
1.55 (1.24 - 1.93) | 2002 | Modelled | IHME |
1.56 (1.25 - 1.95) | 2001 | Modelled | IHME |
1.57 (1.24 - 1.96) | 2000 | Modelled | IHME |
1.56 (1.25 - 1.94) | 1999 | Modelled | IHME |
1.55 (1.24 - 1.94) | 1998 | Modelled | IHME |
1.53 (1.23 - 1.92) | 1997 | Modelled | IHME |
1.52 (1.22 - 1.90) | 1996 | Modelled | IHME |
1.52 (1.21 - 1.90) | 1995 | Modelled | IHME |
1.52 (1.22 - 1.89) | 1994 | Modelled | IHME |
1.52 (1.22 - 1.90) | 1993 | Modelled | IHME |
1.52 (1.22 - 1.90) | 1992 | Modelled | IHME |
1.53 (1.22 - 1.90) | 1991 | Modelled | IHME |
1.53 (1.23 - 1.91) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.55 (0.42 - 0.82) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
36,283 (29,037 - 45,110) | 1990 | Modelled | IHME |
36,368 (29,053 - 45,324) | 1991 | Modelled | IHME |
36,583 (29,298 - 45,712) | 1992 | Modelled | IHME |
36,891 (29,615 - 46,050) | 1993 | Modelled | IHME |
37,269 (29,882 - 46,468) | 1994 | Modelled | IHME |
37,691 (30,131 - 47,101) | 1995 | Modelled | IHME |
38,259 (30,611 - 47,796) | 1996 | Modelled | IHME |
39,005 (31,191 - 48,701) | 1997 | Modelled | IHME |
39,803 (31,957 - 49,843) | 1998 | Modelled | IHME |
40,523 (32,468 - 50,426) | 1999 | Modelled | IHME |
41,032 (32,623 - 51,334) | 2000 | Modelled | IHME |
41,256 (32,973 - 51,428) | 2001 | Modelled | IHME |
41,278 (33,098 - 51,328) | 2002 | Modelled | IHME |
41,214 (33,318 - 51,306) | 2003 | Modelled | IHME |
41,172 (33,188 - 51,304) | 2004 | Modelled | IHME |
41,269 (33,355 - 51,324) | 2005 | Modelled | IHME |
41,502 (33,510 - 51,578) | 2006 | Modelled | IHME |
41,767 (33,681 - 51,821) | 2007 | Modelled | IHME |
42,031 (33,832 - 52,070) | 2008 | Modelled | IHME |
42,274 (33,794 - 52,351) | 2009 | Modelled | IHME |
42,497 (33,860 - 52,530) | 2010 | Modelled | IHME |
42,693 (34,107 - 52,710) | 2011 | Modelled | IHME |
42,880 (34,228 - 52,939) | 2012 | Modelled | IHME |
43,082 (34,528 - 53,139) | 2013 | Modelled | IHME |
43,299 (34,824 - 53,656) | 2014 | Modelled | IHME |
43,550 (35,211 - 53,784) | 2015 | Modelled | IHME |
44,195 (35,528 - 54,909) | 2016 | Modelled | IHME |
45,010 (36,254 - 55,641) | 2017 | Modelled | IHME |
45,599 (36,639 - 56,512) | 2018 | Modelled | IHME |
46,114 (37,158 - 57,370) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
4,300 (3,300 - 6,400) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
1.93 (1.37 - 2.62) | 2019 | Modelled | IHME |
1.89 (1.36 - 2.56) | 2018 | Modelled | IHME |
1.86 (1.38 - 2.47) | 2017 | Modelled | IHME |
1.82 (1.40 - 2.39) | 2016 | Modelled | IHME |
1.8 (1.41 - 2.29) | 2015 | Modelled | IHME |
1.74 (1.39 - 2.19) | 2014 | Modelled | IHME |
1.58 (1.27 - 1.97) | 2013 | Modelled | IHME |
1.56 (1.26 - 1.93) | 2012 | Modelled | IHME |
1.66 (1.33 - 2.08) | 2011 | Modelled | IHME |
1.54 (1.22 - 1.92) | 2010 | Modelled | IHME |
1.74 (1.35 - 2.16) | 2009 | Modelled | IHME |
1.69 (1.32 - 2.11) | 2008 | Modelled | IHME |
1.5 (1.18 - 1.89) | 2007 | Modelled | IHME |
1.34 (1.04 - 1.67) | 2006 | Modelled | IHME |
1.33 (1.04 - 1.68) | 2005 | Modelled | IHME |
1.4 (1.11 - 1.76) | 2004 | Modelled | IHME |
1.5 (1.20 - 1.88) | 2003 | Modelled | IHME |
1.56 (1.24 - 1.95) | 2002 | Modelled | IHME |
1.59 (1.25 - 2) | 2001 | Modelled | IHME |
1.57 (1.24 - 1.97) | 2000 | Modelled | IHME |
1.64 (1.28 - 2.06) | 1999 | Modelled | IHME |
1.64 (1.28 - 2.11) | 1998 | Modelled | IHME |
1.68 (1.29 - 2.17) | 1997 | Modelled | IHME |
1.71 (1.31 - 2.24) | 1996 | Modelled | IHME |
1.73 (1.32 - 2.28) | 1995 | Modelled | IHME |
1.81 (1.36 - 2.36) | 1994 | Modelled | IHME |
1.84 (1.39 - 2.38) | 1993 | Modelled | IHME |
1.82 (1.41 - 2.29) | 1992 | Modelled | IHME |
1.79 (1.40 - 2.22) | 1991 | Modelled | IHME |
1.92 (1.52 - 2.39) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
54 (38 - 74) | 2019 | Modelled | IHME |
53 (38 - 72) | 2018 | Modelled | IHME |
52 (39 - 69) | 2017 | Modelled | IHME |
51 (39 - 67) | 2016 | Modelled | IHME |
50 (39 - 64) | 2015 | Modelled | IHME |
48 (39 - 61) | 2014 | Modelled | IHME |
44 (35 - 55) | 2013 | Modelled | IHME |
43 (35 - 54) | 2012 | Modelled | IHME |
46 (37 - 57) | 2011 | Modelled | IHME |
42 (34 - 53) | 2010 | Modelled | IHME |
48 (37 - 59) | 2009 | Modelled | IHME |
46 (36 - 58) | 2008 | Modelled | IHME |
41 (32 - 52) | 2007 | Modelled | IHME |
36 (28 - 45) | 2006 | Modelled | IHME |
36 (28 - 46) | 2005 | Modelled | IHME |
38 (30 - 47) | 2004 | Modelled | IHME |
40 (32 - 50) | 2003 | Modelled | IHME |
42 (33 - 52) | 2002 | Modelled | IHME |
42 (33 - 53) | 2001 | Modelled | IHME |
41 (32 - 52) | 2000 | Modelled | IHME |
43 (33 - 53) | 1999 | Modelled | IHME |
42 (33 - 54) | 1998 | Modelled | IHME |
43 (33 - 55) | 1997 | Modelled | IHME |
43 (33 - 56) | 1996 | Modelled | IHME |
43 (33 - 57) | 1995 | Modelled | IHME |
44 (33 - 58) | 1994 | Modelled | IHME |
45 (34 - 58) | 1993 | Modelled | IHME |
44 (34 - 55) | 1992 | Modelled | IHME |
43 (33 - 53) | 1991 | Modelled | IHME |
45 (36 - 57) | 1990 | Modelled | IHME |
48 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
24 (17 - 32) | 2019 | Modelled | IHME |
24 (17 - 31) | 2018 | Modelled | IHME |
24 (17 - 31) | 2017 | Modelled | IHME |
24 (17 - 31) | 2016 | Modelled | IHME |
24 (17 - 31) | 2015 | Modelled | IHME |
24 (18 - 31) | 2014 | Modelled | IHME |
24 (18 - 31) | 2013 | Modelled | IHME |
24 (17 - 31) | 2012 | Modelled | IHME |
23 (17 - 31) | 2011 | Modelled | IHME |
24 (17 - 31) | 2010 | Modelled | IHME |
23 (16 - 30) | 2009 | Modelled | IHME |
23 (17 - 31) | 2008 | Modelled | IHME |
24 (17 - 32) | 2007 | Modelled | IHME |
25 (18 - 32) | 2006 | Modelled | IHME |
25 (18 - 33) | 2005 | Modelled | IHME |
25 (18 - 33) | 2004 | Modelled | IHME |
25 (18 - 33) | 2003 | Modelled | IHME |
25 (18 - 32) | 2002 | Modelled | IHME |
25 (18 - 33) | 2001 | Modelled | IHME |
25 (17 - 33) | 2000 | Modelled | IHME |
24 (17 - 32) | 1999 | Modelled | IHME |
24 (17 - 32) | 1998 | Modelled | IHME |
24 (17 - 32) | 1997 | Modelled | IHME |
24 (17 - 32) | 1996 | Modelled | IHME |
24 (17 - 33) | 1995 | Modelled | IHME |
25 (17 - 32) | 1994 | Modelled | IHME |
25 (17 - 32) | 1993 | Modelled | IHME |
25 (18 - 32) | 1992 | Modelled | IHME |
25 (18 - 32) | 1991 | Modelled | IHME |
24 (17 - 32) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Planned for 2020
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.01
(%)
2019, latest modelled
(0.01 - 0.02(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines